Frontline employees and seniors are first priority of Govt for Covid-19 vaccine administration.

Key Points: 

• According to government reports, India’s priority list of people listed to be given the anti-coronavirus disease (Covid-19) vaccine.
• The plan has not yet been completed and is currently in the works,” added the official.
• A paper on this, which is in its final stages of preparation and has already been shared with state governments.
• India has also used its development potential to pre-order 600 million doses of anti-Covid-19 vaccines.

According to government reports, India’s priority list of people listed to be given the anti-coronavirus disease (Covid-19) vaccine, as so when available for use has been likely to include older people who’ve been 65 years of age and older.

Vaccine firstly will be given to: 

“Vaccine administration is likely to take place in stages, according to the discussions, and top priority is to be given to high-risk population groups that include frontline staff, such as healthcare personnel and people from other departments working on-site to handle the outbreak, and elderly people who are at higher risk of contracting serious illness due to low immunity and comorbidities,”.

“The plan has not yet been completed and is currently in the works,” added the official.

The National Vaccine Administration

The centre was founded in August by the National Vaccine Administration Expert Group, headed by Dr VK Paul as well as co-chaired by Union Health Secretary Rajesh Bhushan, which is also in the process of drafting a time-bound policy to ensure that the people are vaccinated as early as the vaccine is released publicly.

Bhushan during a press conference:

A paper on this, which is in its final stages of preparation and has already been shared with state governments, has been drawn up; their inputs have been received. We are still in the process of finalizing the lists of different target population groups that will be provided if and when the vaccine becomes available.

We are also in close cooperation with the state governments as well as the other central ministries on vaccine administration,” Bhushan said during a press conference on the country’s Covid-19 condition on Tuesday.

As per the AMCs analysis:

India has also used its development potential to pre-order 600 million doses of anti-Covid-19 vaccines, according to a new global review of advance consumer commitments (AMCs) for experimental vaccines until October 8. Negotiations are underway for another 1 billion doses, enough to vaccinate at least half of the population.